• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

SNM SCANcast: Bioscan offers advanced SPECT/CT preclinical scanner

Article

In an audio interview with Victor Tchiprout, director of sales and marketing for Bioscan, hear how combining an advanced SPECT collimation system with a four-detector gantry promises improved image quality -- and how this could speed new drug development.

The development of SPECT and PET systems for preclinical imaging has resulted in major advances in nuclear medicine over the past 20 years, according to Simon R. Cherry, director of the Center for Molecular and Genomic Imaging at the University of California, Davis. The availability of such systems not only minimizes the sacrifice of laboratory animals, it increases the validity of research by allowing the long-term study of animal subjects. One device, the NanoSPECT/CT, featured at the 2006 Society of Nuclear Medicine meeting, raises the molecular imaging of rodents to a new level, according to Victor Tchiprout, director of sales and marketing for Bioscan, a Washington, D.C.-based developer of advanced instrumentation for the synthesis and detection of radiolabeled compounds. Hear how combining an advanced SPECT collimation system with a four-detector gantry promises improved image quality - and how this could speed new drug development.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.